Skip to content ↓

MIT Museum open daily this summer

Starting Monday, July 11, the MIT Museum will be open every day, offering families, tourists and others more time to explore its exhibits on science and technology, architecture and design, and oceanography and ship design.

Normally closed on Mondays, the museum will be open seven days a week through Aug. 29.

Exhibitions currently on view include "Mind and Hand: The Making of MIT Scientists and Engineers," an exploration of how an MIT education has changed through the years; "Robots and Beyond: Exploring Artificial Intelligence @ MIT," an interactive excursion into the world of artificial intelligence at MIT; "Holography: The Light Fantastic," an eye-popping display of works from the Institute's holography collection-the world's largest; "Gestural Engineering: The Sculpture of Arthur Ganson," ingenious, philosophical and witty kinetic sculptures once described as "Rube Goldberg meets Jean-Paul Sartre"; and "Flashes of Inspiration: The Work of Doc Edgerton," a multimedia celebration of the life and work of MIT legend Harold "Doc" Edgerton (1903-1991), the developer of the electronic strobe whose stop-motion photography is world famous.

In addition to these ongoing exhibits, "InvenTeams Showcase," a show of inventions made by high school teams participating in the Lemelson-MIT Program, is on view through Aug. 14.

For more information, call 617-253-4444 or visit http://web.mit.edu/museum.

Related Links

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story